Intuitive Surgical (NASDAQ:ISRG) Rating Increased to Outperform at Oppenheimer

Intuitive Surgical upgraded at Oppenheimer on robotic surgery market growth

Oppenheimer upgrades Intuitive Surgical to outperform with $500 target, citing robot surgery growth and limited J&J Ottava impact. Read more here.

Intuitive Surgical (ISRG) Stock Has Plunged 33% in 2026. Here's Why One Fund Manager Remains Bullish -- and Why I Do, Too.

The stock may be down sharply, but don't count it out -- and the lower price makes it more attractive.

Intuitive Surgical (NASDAQ:ISRG) Rating Increased to Outperform at Oppenheimer

Oppenheimer raised Intuitive Surgical from a "market perform" rating to an "outperform" rating and set a $500.00 price target on the stock in a research note on Wednesday.